These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5861506)

  • 21. Randomized clinical trial of norfloxacin for shigellosis.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
    Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of bacillary dysentery].
    Gioieni A
    Clin Ter; 1980 Jan; 92(2):197-80. PubMed ID: 7389276
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
    Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
    Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Amoxicillin in the treatment of children with shigellosis].
    Prado V; Cohen J; Banfi A
    Rev Chil Pediatr; 1979; 50(3):27-31. PubMed ID: 261622
    [No Abstract]   [Full Text] [Related]  

  • 26. Nalidixic acid for shigellosis.
    McCormack JG
    Lancet; 1983 Nov; 2(8358):1091. PubMed ID: 6138641
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 28. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
    Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
    J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiological and therapeutic considerations on 46 cases of shigellosis in childhood].
    Pitruzzella E; Raspone C; Pitruzzella D; Lo Iacono G
    Pediatria (Napoli); 1981; 89(2):219-33. PubMed ID: 7312491
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing resistance to nalidixic acid in Shigella subgroups in a comparative study between 2001-2003 and 2004-2006.
    Mamishi S; Mashoori N; Mahboobi N; Pour Akbari B
    Singapore Med J; 2009 Aug; 50(8):791-3. PubMed ID: 19710978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological and clinical characteristics of shigellosis in rural Bangladesh.
    Baqui AH; Zaman K; Yunus M; Mitra AK; Hossain KM; Banu H
    J Diarrhoeal Dis Res; 1988 Mar; 6(1):21-8. PubMed ID: 3251937
    [No Abstract]   [Full Text] [Related]  

  • 36. Changing antibiotic sensitivity patterns in shigellosis.
    Lamabadusuriya SP; Devasiri IV; Jayantha UK; Perera C
    Ceylon Med J; 1991 Dec; 36(4):159-61. PubMed ID: 1807844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Considerations on dysentery caused by Shigella with multiple resistance to antibiotics].
    Brauner E; Cuciureanu G; Hurmuzache T; Turcu T; Grigoriu A; Cercel I
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(3):221-6. PubMed ID: 5344218
    [No Abstract]   [Full Text] [Related]  

  • 38. Shigellosis (antibiotic resistance and transfer of R-factor).
    Gaikwad S; Deodhar LP
    J Postgrad Med; 1985 Jan; 31(1):24-7. PubMed ID: 3900357
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.
    Niyogi SK
    Clin Microbiol Infect; 2007 Dec; 13(12):1141-3. PubMed ID: 17953700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shigellosis in Puducherry.
    Dhodapkar R; Acharya NS; Harish BN; Parija SC
    Indian J Med Res; 2008 Jun; 127(6):621-2. PubMed ID: 18765885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.